
Zachary Nelson, PharmD, BCIDP, BCPS, discussed the past 2 influenza seasons and how they could help predict vaccination and illness rates.

Zachary Nelson, PharmD, BCIDP, BCPS, discussed the past 2 influenza seasons and how they could help predict vaccination and illness rates.

The results of 2 analyses in the United Kingdom show a small increase in the potential for intracranial thrombosis after vaccination.

The median duration of discomfort and pain was shorter in the vaccinated group than in the placebo group, at 21 days and 24 days, respectively, investigators say.

How would you respond to these patient questions?

Institute for safe medication practices receives hundreds of reports of incorrect doses for children.

Results of the analysis may help inform future COVID-19 vaccine development, investigators say.

But results of analysis show that the positive effects of vaccination still outweigh the potential adverse events.

The continued upward trend in testing and vaccination demand, coupled with staffing shortages, technology gaps, and never-ending to-do lists, exacerbates spikes in patient volume and workload for pharmacy professionals.

The claim is based on requested exemption from administering immunizations because of "needle phobia."

The vaccine targets the outer surface protein A of Borrelia burgdorferi, which is the bacteria that cause Lyme disease.

But vaccines do not cause infertility or harm pregnancy chances, Boston University School of Public Health research results show.

Ashley Woodyard, a PharmD candidate at the Touro University California College of Pharmacy in Vallejo and co-author of an article in the January 2022 issue of Pharmacy Times®, discussed the article and the benefits of pharmacy technicians as vaccine administrators.

But study results show some are not sold on performing the task; adequate training can build their confidence.

Gaps in vaccination rates may be related to access and not just distrust and skepticism, investigators from Ohio State University find.

Investigators learned that the degree of response depended on whether an individual has had 1, 2, 3, or 4, exposures through infection, vaccination, or both.

Both data sets confirm previously announced results showing that the boost protects against the variant.

Investigators analyzed data to determine the outcomes and risk factors for severe cases and how individuals with inflammatory bowel disease are affected.

New study results show that there are more incidences of this inflammation of the heart muscle related to not being vaccinated than there are to the vaccine itself.

Results of an analysis show that 3 doses of either Oxford/AstraZeneca COVID-19 or Pfizer BioNTech COVID-19 neutralizes the variant.

A sizable number of clinical trial participants say they had at least 1 AE, with fatigue and headaches the most common.

A new analysis suggests that boosters can provide ongoing prevention of death and hospitalization.

Amid the COVID-19 pandemic, health care providers are focusing on the health of younger individuals.

Vaccines can help protect against certain strains of HPV, the virus that causes genital warts.

Pharmacists should stay abreast of changes in formulations and recommendations, foster communication with their staff, and plan proactively.

Earlier analyses also demonstrated the same potential of BBV152 against SARS-CoV-2 alpha, beta, delta, zeta, and kappa.